Page 5 - 202005

CHINA PHARMACY

Volume 31，Number 5，March 15，2020

Semimonthly

Selected Table of Contents

Construction of Integrated Emergency Management Model for Novel Coronavirus Pneumonia Epidemic Prevention
and Control in Hospital Pharmacy Department ……………………………………………………………………

………………… DONG Shujie，YANG Li，CHEN Chen，KONG Xianwei，CAI Zheng，DU Yawei，LIU Fang，
ZHU Jinping，JIANG Hua，HUANG Jing，ZHANG Xianhua，WEN Jian，LI Xue，HAN Tao，GUO Hongying，
CUI Jing，SHUAI Yuan，LI Jing，YAN Yingying，LIU Wei，LI Huibo，YANG Yiheng，LI Zijian，ZHAO Rongsheng（513）
Novel Coronavirus Infection Response：Prevention and Control Strategies Based on Drug，Material Supply and
Emergency Management …………………………………………………………………………… YANG Li，XU
Xiaohan，CHEN Chen，YANG Guang，CHEN Lihua，HE Xiaojie，YANG Yiheng，ZHAI Suodi，ZHAO Rongsheng（518）
Exposure Protection Countermeasures for Novel Coronavirus Infection in Hospital Pharmaceutical Staff …………
……… YAN Yingying，YUAN Xiaoning，YANG Yiheng，YANG Li，LIU Fang，ZHAI Suodi，ZHAO Rongsheng（523）
Evidence-based Pharmaceutical Practice Responding for Novel Coronavirus Pneumonia Epidemic ………………
………………………………………… YI Zhanmiao，GUO Hao，QI Shibo，ZHOU Tiantian，ZHAO Rongsheng（527）
Establishment of Hospital Pharmacy Prevention and Control Strategies for Novel Coronavirus Infection Based on
5M1E Analysis Method ………………………………………………………………………………………………
………… YING Yingqiu，REN Zhenyu，SHI Weilong，ZHAO Yue，YANG Li，ZHAO Rongsheng，ZHAI Suodi（532）

Practice of Pharmaceutical Care in Designated Hospital under the Condition of Novel Coronavirus Pneumonia
Epidemic …………………………… CHEN Jingze，HU Mingle，LUO Jiawei，ZHANG Wei，ZHANG Dingyu（536）
Definition，Measurement and Evaluation of Drug Clinical Comprehensive Value from a Perspective of the Public
Decision-making ……………………………………… KONG Fanxin，MA Aixia，LI Hongchao，TANG Wenxi（539）
Reform Course and Driving Factors of American Medicare Payment Mode and Implication for China …………
……………………………………………………… ZHU Zirong，ZHANG Lingli，YAN Jianzhou，SHAO Rong（545）
Research on Drug Safety Governance in Australia and Its Enlightenment to China …………………………………
………………………………………………………………………………………… CHEN Jiani，CHEN Yongfa（549）
Correlation Analysis of Storage Life and Effective Composition Content with Color Value of Carthamus tinctorius
…………………………… WANG Jie，SU Shaofeng，YAO Renchuan，REN Chaoxiang，PEI Jin，CHEN Jiang（554）
Study on Network Pharmacology of Superior Components of Fagopyrum dibotrys …………………………………
………………………………………………………………………… YAN Xueling，SHI Zheng，ZHANG Yun（558）
Study on the Mechanism of Bambuterol Hydrochloride in the Improvement of Chronic Obstructive Pulmonary
Disease Model Rats …………………………………………………………………………………………………
……………………… DU Mengjiao，ZHONG Yanmei，DENG Shanbin，YU Chuqin，CHEN Lishi，CAI Yanqu（564）
Simultaneous Determination of the Contents of 12 Flavonoids in Quzhiqiao from Different Collection Places by

HPLC ………………… FENG Jingqian，HU Weinan，XU Liping，LI Jiangyan，WANG Siwei，SONG Jianfeng（571）
Content Determination of 4 Indicator Components in Shengyu Decoction Lyophilized Powder by HPLC ………
…………… DONG Danhua，LIU Yujun，LI Yanan，HU Xianghao，SUN Ping，LI Ting，LIU Juyan，GAO Peng（576）
Study on Detection Methods for Related Substances in Fidaxomicin Raw Material ………………………………
……………… WANG Yali，LIU Yue，BAN Lu，LI Xiaolu，CHENG Xiaokun，REN Fengzhi，ZHANG Xuexia（581）
Consistency Evaluation of in vitro Quality of Nitroglycerin Tablet Reference Preparation and Imitative Preparation
……………… SUN Ting，JIANG Jianguo，ZHANG Jing，ZHANG Xiru，XU Yanmei，WANG Liu，JIANG Ning（586）